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Aims: The aims of this study were to evaluate the outcomes of treatment among hospitalized patients
with diabetic foot ulcers, the risk factors for non-healing ulcers, and the rate of major amputation among
Thai patients.
Methods: A retrospective study of hospitalized diabetic foot patients treated at Theptarin Hospital during
the period of 2009e2013. The complete healing rate was assessed at 12 months after admission.
Results: During the study period, 232 patients (123 males and 109 females) with 262 admissions were
included (mean age 65.6  11.9 years, mean duration of diabetes 17.2  9.9 years) with a mean follow-up
of 17.5  16.7 months. Major amputations were performed in 4.2% of the patients and peripheral vascular
disease (PVD) was a predictive factor (OR 5.25; 95% CI [1.43e19.29]; p-value 0.006). Complete healing
(including minor amputations) was achieved in 82.1% of the admissions. Only DFU of the heel was a
statistically signiﬁcant (OR 3.34; 95% CI [1.11e10.24]; p-value 0.041) predictor of non-healing ulcers.
Three patients (1.1%) died during hospitalization.
Conclusions: Management of diabetes-related foot ulcers with a multidisciplinary approach resulted in a
limb salvage rate that was greater than 90% and a complete healing rate that was greater than 80%.
Successful management of diabetic foot ulcers might be possible in Thailand utilizing this approach.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Diabetic foot problems are the most common cause of hospi-
talization among patients with diabetes and often require long-
term hospital admissions. Such problems have been estimated to
affect 25% of all diabetic individuals during their lifetime [1]. These
problems represent considerable patient morbidity and are asso-
ciated with substantial health-care costs. Over 85% of lower limb
amputations are preceded by foot ulcers and diabetes remains the
most common cause of non-traumatic amputation in Western
countries [2].
In the developed countries, the amputation rate has been
reduced by 50% via proactive management with a multidisci-
plinary approach [3]. A multidisciplinary approach providesBY-NC-ND license (http://
interest.
haroen).
Inc. Open access under CC BY-NC-ND licemeticulous wound care, debridement, adequate vascular supply,
metabolic control, improvement of nutritional status, appropriate
antibiotic treatment, and non weight-bearing, which are the car-
dinal features of the treatment of diabetic foot syndrome. Patient
education and, in some cases, assisted self-care for patients pro-
vided by family member are also crucial for the prevention of
diabetic feet in high-risk patients [4]. Evidence from a tertiary care
unit in Thailand revealed that a multidisciplinary approach that
focused on clear guidelines and collaboration between specialists
resulted in a 70% decrease in the incidence of major amputation
and a 60% decrease in the incidence of minor amputation
[5].Therefore, diabetic foot ulcers should be managed under the
care of a multidisciplinary team with expertise in the many facets
of care.
In our center, diabetologists take the lead role in foot care within
the multidisciplinary team outlined in Figure 1. The advantage of
this system is the emphasis on optimal glycemic control over the
course of diabetic foot ulcer treatment. Furthermore, because pa-
tients with diabetic foot problems are also likely to harbor other
associated complications of diabetes, such as nephropathy, reti-
nopathy, ischemic heart disease, and cerebrovascular disease, thense.
Figure 1. Outline of hospitalize diabetic foot management which diabetologists take the lead role in the foot care multidisciplinary team.
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morbidities during the selection of treatment.
A retrospective study from Thailand revealed that a history of
foot ulcer among Thai diabetic patients was associatedwith a three-
fold increase in mortality rate compared to those without such
history and that the average age of death was earlier than that of
Caucasian patients (64.8 years versus 74.2 years) [6]. Unfortunately,
there are no national diabetes outcome indicators, particularly
outcomes of hospitalized diabetic foot patients, that are routinely
collected in Thailand. Therefore, the aim of this study was to eval-
uate the outcomes of treatment among hospitalized patients with
diabetic foot ulcers, the risk factors for non-healing ulcers, and the
rate of major amputation in a multi-discipline diabetes center that
was facilitated and led by diabetologists.
Materials and methods
This retrospective study was approved by the institutional re-
view board (IRB) committee of Theptarin Hospital, Bangkok,
Thailand. The medical histories of all hospitalized diabetic foot
patients who were treated at Theptarin Hospital during the period
from 2009 to 2013 were analyzed. Theptarin Hospital is one of the
most comprehensive diabetes centers in Bangkok, and over 4000
registered diabetic patients were treated at this hospital during the
study period.
Diabetic foot ulcer (DFU) was deﬁned as a full thickness wound
below the ankle in an individual with diabetes. Acute DFUs were
deﬁned by a duration of DFU less than 14 days, and chronic DFUs
were deﬁned by a duration of DFU greater than or equal to 14 days.
The commonly used Wagner classiﬁcation deﬁnes wounds by the
depth of ulceration and the extent of gangrene [7]. However, the
University of Texas system (UT classiﬁcation) grades wounds ac-
cording to the depth and then stages the wounds according to the
presence or absence of infection and ischemia [8]. In this study, the
wounds were classiﬁed with both systems. The end point of this
study was “complete wound healing,” which refers to the complete
epithelialization of the overlying soft-tissue wound. Non-healingulcers were deﬁned as wounds that had not healed by 12 months
after admission. Amputations were divided into minor (up to below
the ankle level) and major amputations (above the ankle level). The
limb salvage rate was deﬁned as the percentage of patients who
avoided major amputations. Peripheral vascular disease (PVD) was
classiﬁed according to revised Trans-Atlantic Inter-Society
Consensus (TASC II) classiﬁcation [9].
The patient proﬁles, types of diabetic wounds, gradings of the
DFUs, co-morbidities, methods of treatment, and ﬁnal outcomes
were collected. The complete healing rate was assessed 12 months
after admission. The risk factors for non-healing ulcers and major
amputations were also determined.
Statistical analyses
Continuous values are given as the mean  SD and categorical
variables are given as proportions. Unpaired t-tests were performed
to compare the numerical values between two groups when the
data were normally distributed. When the data were not normally
distributed, ManneWhitney tests were used for comparisons. The
chi-square test was used to compare the factors that were associ-
ated with non-healing ulcers and major amputations. p-Values
<0.05 were considered statistically signiﬁcant. All statistical ana-
lyses were conducted using the Statistical Package for the Social
Sciences (version 17.0; SPSS, Chicago, IL, USA).
Results
During the study period, 232 patients (123 males and 109 fe-
males) with 262 admissions were included (mean age: 65.6  11.9
years, mean duration of diabetes: 17.2  9.9 years), and the mean
follow-up time was 17.5  16.7 months. The median length of stay
was 7 (range 1e63) days. The reasons for admissions included un-
controlled infection (38.9%), PVD (17.6%), severe hyperglycemia
(15.4%), worsening of renal function (14.3%), co-morbidity (12.2%),
and other (1.6%). Themean bodymass index (BMI) was 25.4 4.2 kg/
m2, and the average HbA1c was 8.9  2.4% (74 mmol/mol). The
Table 1
Baseline characteristics of the hospitalized DFU patients according to wound type
Baseline characteristics Neuropathic wound
(N ¼ 149)
Ischemic wound
(N ¼ 36)
Neuro-ischemic
wound (N ¼ 77)
Total
(N ¼ 262)
Age (years) 60.8  11.1 70.9  10.8 72.4  9.3 65.6  11.9
Male (%) 53.0% 50.0% 53.2% 52.7%
BMI (kg/m2) 26.2  4.5 24.7  4.0 23.7  3.1 25.4  4.2
Duration of DM (years) 15.9  9.1 16.0  9.7 20.7  10.8 17.2  9.9
HbA1c (%) 9.4  2.5 8.2  2.0 8.1  1.9 8.9  2.4
Diabetic nephropathy (%) 39.5% 50.0% 49.4% 44.0%
Diabetic retinopathy (%) 60.6% 33.3% 40.0% 53.0%
Previous DFU (%) 49.0% 44.4% 53.2% 49.6%
Smoking (%) 21.4% 21.9% 22.4% 22.0%
Wagner  grade 3 36.2% 66.7% 50.7% 44.7%
Length of stay (days) 8.0  8.5 13.6  12.1 14.6  11.6 10.7  10.5
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were 21.0% and 44.0%, respectively. Twenty-two percent of the pa-
tients had histories of current or previous smoking. One hundred
ﬁfteen patients (49.6%) had prior histories of foot ulcers. Major and
minor amputations were performed for 11 and (4.2%) and 49 pa-
tients (18.7%), respectively. The details of the baseline characteristics
are shown Table 1.
The diabetic foot ulcers (DFUs) were classiﬁed into neuropathic
wounds (56.9%), ischemic wounds (13.7%), and mixed-typewounds
(29.4%). Among all ulcers, 89.3% were localized to the toe and
forefoot areas, 6.9%were localized to the heel and 3.8% were local-
ized to the ankle area. Acute DFUs were present in 31.7% of the
patients. The distribution of the ulcers according to the Wagner
classiﬁcation was as follows: Wagner 1 (22.5%); Wagner 2 (32.8%);
Wagner 3 (32.1%); Wagner 4 (11.8%); and Wagner 5 (0.8%). Appli-
cation of the UT classiﬁcation revealed that UT stages C and D
comprised 56.5% of the admissions. Charcot joints were presented
in 8.8% of the cases.
Open surgical bypass revascularizations were mandatory for six
patients during the study period and including two aortobifemoral
bypasses, one femorofemoral bypass, two femoropopliteal artery
bypasses and one femorotibial vessel bypass. Primary angioplasties
were performed in 55 patients (48.7% of the PVD patients) from
2009 to 2013. Limb salvage was achieved in83.3% of these patients.
TASC type C and D lesions were present in 84.0% of the patients who
underwent angioplasty.
Regarding the bacteriologies of the DFUs, a total of 224 bacte-
rial isolates were obtained from 170 DFUs (64.9%). Gram-negative
bacilli were more prevalent (58.8%) than were gram-positive cocci
(41.2%). The most commonly isolated organism was Escherichia coli
(18.7%), followed by Pseudomonas spp. (12.6%) and Staphylococcus
aureus (11.8%). Mixed organisms were found in 33.6% of the DFUs
and were most prevalently a combination of gram-negative or-
ganisms. Regarding the acute DFUs, methicillin-sensitive S. aureus
(MSSA) was the most commonly isolated organism (20.8%),Table 2
Comparison of the clinical characteristics of the healed (including minor amputations) a
Baseline characteristics Healed ulcer (N ¼ 232)
Age (years) 65.1  11.6
HbA1c (%) 8.8  2.3
Serum creatinine (mg/dL) 1.6  1.7
Duration of ulcer (days) 60.0  104.2
Wagner  grade 3 36.2%
Location of ulcer (%)
Toe 50.5%
Forefoot 40.9%
Heel 5.6%
Ankle 3.0%
a The data were not normally distributed, so ManneWhitney tests were used for thefollowed by mixed gram-positive and negative organisms (19.4%).
Regarding the chronic DFUs, mixed gram-positive and -negative
organisms were most commonly found (22.9%), followed by
Pseudomonas spp. (8.4%). The antibiotic sensitivity proﬁles of the
bacteria were studied, and 6.5% of the gram-negative bacilli were
found to be extended-spectrum b-lactamase ESBL producers, and
3.5% of the gram-positive cocci were methicillin-resistant S. aureus
(MRSA).
Major amputations were performed in 6.0% of the patients, and
peripheral vascular disease (PVD) was a predictive factor (OR 5.25;
95% CI [1.43e19.29]; p-value 0.006). Complete healing (including
minor amputations) was achieved in 82.1% of the patients. Only
DFU in the heel was found to be a statistically signiﬁcant (OR 3.34;
95% CI [1.11e10.24]; p-value 0.041) predictor of non-healing ulcers
as shown in Table 2. This association occurred independently of the
presence of PVD. Three patients (1.1%) died of cardiac arrests that
were likely due to the development of ischemic heart disease
during hospitalization. The mortality rates across the entire cohort
at one and three years after discharge were 5.7% and 9.5%, respec-
tively. Among the patients who underwent major amputations, the
mortality rates at one and three years after discharge were 27.3%
and 45.5%, respectively.
Discussion
Diabetic foot ulcers (DFUs) have been neglected in health-care
research and planning, and DFUs are often accompanied by other
diabetic complications. It is not uncommon to observe cardiovas-
cular or cerebrovascular events during the management of diabetic
feet [10]. Globally, diabetic foot complications remain the major
medical, social, and economic problem for all types of diabetes.
Without early and optimal interventions, wounds can rapidly
deteriorate and lead to unnecessary amputations. Following am-
putations, patients not only suffer the clinical and psychological
consequences of limb loss, but amputation itself is predictive of and non-healed patients
Non-healed ulcer (N ¼ 30) p-Value
67.5  12.9 0.071
9.0  2.8 0.119
2.4  2.6 0.699
41.2  42.9 0.540a
66.7% 0.212
33.3% 0.613
40.0% 0.845
16.7% 0.041
10.0% 0.093
comparisons.
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females and prostate cancer in males [11].
Data from the Thailand diabetes registry (TDR) project, which is
a cross-sectional study of 9419 diabetic patients from 11 tertiary
care hospitals across Thailand, has revealed that the prevalence of
lower extremity amputation among Thai diabetic patients is 1.5%
and that patients with histories of ulcers, peripheral vascular dis-
ease, diabetic retinopathy and insulin injection are at higher risks
[12]. These observations clearly indicate the need for regular
screening to identify such high-risk individuals. The inpatient
management of DFUs also has a signiﬁcant ﬁnancial affect, and
DFUs are associated with prolonged lengths of hospitals stays. The
EURODIALE study examined total direct and indirect costs over one
year across several European countries [13]. The average total cost
based on 821 patients was approximately 10,000 euros, and hos-
pitalization representing the greatest direct cost. In Thailand, a
study from a provincial hospital revealed that the median cost of
hospitalization was USD$ 190 for patients with diabetic feet
compared to USD$ 101 for patients without complications [14].
To achieve best outcome in terms of amputation reduction due
to diabetes, themultidisciplinary team concept must be adopted for
both the general management of diabetes and the management of
associated complications including foot ulcers [15]. In this study, we
achieved a limb salvage rate greater than 90% and a complete
healing rate greater than 80%via a multidisciplinary team approach
involving diabetologists as leaders and center coordinators.
Therefore, these data reafﬁrm that the organization of care is one of
the main determinants of the outcome of diabetic foot ulcers.
Patients with diabetic foot ulcers suffer from multi-organ dis-
ease. A large prospective study in Sweden that was conducted in
both out- and in-patient settings revealed that nearly one-ﬁfth of
the patients with unhealed ulcers died from co-morbid conditions
and that the severity of PVD was associated with healing rate and
amputation [16]. The factors that are related outcome are complex
due to the variation in the deﬁnitions of outcome across studies
[17]. It is difﬁcult to perform long-term studies on this patient
group because the time to heal can be very long. Unfortunately, no
other studies of the outcomes of DFU among patients hospitalized
in Thailand are available. In the present study, our patients were
comparable in terms of co-morbidities and demographic data, but
they were younger than the patients who were included in a
Swedish series (65 years versus 75 years). Our study revealed that
the presence of PVD increased the risk of major amputation by
more than 5-fold. PVD tends to occur at a younger age among pa-
tients with diabetes and is more likely to involve distal vessels.
Although current report of PVD among Asians have reported low
rates that range between 3 and 6%, while these rates are 25e45%
among Westerners [18], the prevalence of PVD increases with age.
Consequently, it is expected that the prevalence of PVD among
Asians will signiﬁcantly increase in the near future.
Recently, primary angioplasty has been regarded as the primary
therapeutic strategy for diabetic patients with critical limb ischemic
ulcers because it is considered to be a less invasive and effective
method to restore the distal ﬂow toward the ischemic tissue zones
[19].One study showed that, when endovascular revascularization
techniques were utilized, only 10 of 191 patients (5.2%) later
required major amputations [20]. In the present study, the results
from the patients who underwent angioplasty revealed a limb
savage rate of 83.3%. Traditionally, primary infra-inguinal angio-
plasty is the established treatment modality for infra-inguinal
arterial occlusive disease; however, supra-inguinal (aorto-iliac)
disease might be amenable to angioplasty, and good long-term
results have been achieved at low risk as compared to open
bypass surgery [21,22]. The trend of revascularization procedures in
our center has shifted from open bypass surgery to primaryangioplasty due to the co-morbidities of open bypass surgery and
the limited availability of experienced vascular surgeons. Conse-
quently, primary angioplasty might be considered to be an
acceptable option for some patients with severe limb ischemia and,
when technically feasible, might be the favored initial option.
The interesting data from our study revealed that the risk of
non-healing was more than three times higher among patients
with heel ulcers than among patients with ulcers at other sites. This
ﬁnding is consistent with previous reports that heel ulcers are
associated with the poorest prognoses among all diabetic foot ul-
cers [23,24]. Diabetic heel ulcers are particularly challenging to
treat because ﬂap reconstruction of the heel area is difﬁcult.
Moreover, signiﬁcant debridement or amputation of the heel rarely
leaves a functionally walking patient. Several classiﬁcation systems
for DFUs had been devised over the years and include the Wagner
classiﬁcation system, the University of Texas system, and the more
recent PEDIS classiﬁcation. The InternationalWorking Group on the
Diabetic Foot (IWGDF) has proposed the PEDIS classiﬁcation, which
grades ulcers based on Perfusion (arterial supply), Extent (area),
Depth, Infection, and Sensation [25]. However, none of these clas-
siﬁcations account for measurements of neuropathy or ulcer loca-
tion. The problem of heel ulcers will increase in conjunction with
the increase in the diabetic and aging populations. Heel ulcers in
patients with diabetes have the potential to deteriorate rapidly, and
therefore frequent re-evaluations are necessary.
In the present study, major amputations were required for the
patients with advanced foot infections, the medically compromised
patients, and occasionally patients with severe Charcot deformities.
Although lower extremity amputation (LEA) is regarded as amarker
of the quality of foot care among diabetics, LEA rates among pa-
tients with diabetes vary by country, healthcare system, cost, and
payer [26]. Amputation is not only a marker of disease but also of
disease management. The decision to operate is based on by many
factors. Primary amputation might be the best option for some
patients, and the early identiﬁcation of these patients might obviate
the use of inappropriate, potentially dangerous, and costly pro-
cedures. Whenever a major amputation is planned, the option of
revascularization should be considered ﬁrst. All patients who have
undergone a major amputation are at a high risk of subsequent
contralateral amputation, and thus surveillance programs for the
remaining feet are crucial.
The occurrence of DFU is a pivotal event in the life of a person
with diabetes and a marker of serious disease and co-morbidities.
Other high-risk patient include those with end-stage renal disease
based on previous data that revealed that up to two-thirds of people
on dialysis will die within two years of amputation [20]. Therefore,
these high-risk patients also need to be evaluated thoroughly
regarding medical conditions and particularly renal failure [27].
The strengths of this study include its relatively large sample size
and that it is the ﬁrst comprehensive report of hospitalized Thai DFU
patients for whom a multi-disciplinary approach was employed.
However, several limitations also exist. First, the retrospective na-
ture of the study resulted in relatively incomplete data and missing
data regarding some aspects such as foot deformities and complete
vascular assessments. Second, the bacteriological proﬁles in our
study were derived primarily from patients who received prior
antibiotic treatment from previous hospitals, which limits the
generalizability of the ﬁndings. Finally, as discussed earlier, the
amputation ratemight not be a goodmarker of the quality of clinical
care, and better indicators are required for future studies.
In conclusion, the successful management of diabetic foot ul-
cers requires a dedicated team of multiple specialists and a well-
deﬁned referral pattern within each community. Our data
demonstrated that the use of multidisciplinary approach resulted
in the achievement of limb salvage rate above 90% and a complete
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accessible to all patients with diabetes in Asia. Reductions in the
numbers of amputation that result from diabetes can be widely
achieved if proper strategies, such reimbursement systems,
referral systems, preventive policies, and medical personnel
training, are executed at the national level.References
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